A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
Clinical trial NCT05394285 · COMPLETED
Trial details
- NCT number
- NCT05394285
- Sponsor
- Henan Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-21
- Primary completion
- 2025-06-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.